Literature DB >> 22983868

Utility of bronchoalveolar lavage in the diagnosis of pulmonary infection in children with haematological malignancies.

U Rao1, A Piccin, A Malone, K O'Hanlon, F Breatnach, A O'Meara, M McDermott, K Butler, N O'Sullivan, J Russell, A O'Marcaigh, O P Smith.   

Abstract

BACKGROUND: Fibre-optic bronchoscopy with bronchoalveolar lavage (BAL) is a safe procedure and is associated with low morbidity and mortality in immunocompromised children. Although many studies have highlighted the advantages of positive BAL results in the diagnosis of pulmonary infections, there have been few reports examining the impact of a negative BAL result on clinical management in immunocompromised children on empiric broad-spectrum antimicrobial therapy. AIM: The aim of this study was to evaluate BAL in the diagnosis of pulmonary infections in children with haematological malignancies who develop pneumonia unresponsive to empiric antimicrobial therapy, and also to determine whether a negative BAL result contributed to the clinical management of these patients.
MATERIALS AND METHODS: A retrospective review of 44 BAL procedures performed in 33 children with haematological malignancy diagnosed and treated at Our Lady's Children Hospital, Crumlin, Dublin 12, Ireland, over a 10-year period was carried out.
RESULTS: We identified a pathogen causing pneumonia in 24 of 44 BAL procedures (54.5 %). The BAL procedure resulted in modification of antimicrobial treatment after 20 of 24 procedures with positive results (83.3 %) in 16 of 20 patients (80 %). Management was changed after 8 of 20 procedures with negative results (40 %) in 8 of 18 patients (44.4 %). The procedure was well tolerated in all patients.
CONCLUSIONS: Our study supports the use of bronchoscopy with BAL as a diagnostic intervention in this patient population. We consider BAL a safe procedure from which both positive and negative results contribute to the patient's clinical management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983868     DOI: 10.1007/s11845-012-0852-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

Review 1.  Lung infections after cancer chemotherapy.

Authors:  Sandro Vento; Francesca Cainelli; Zelalem Temesgen
Journal:  Lancet Oncol       Date:  2008-10       Impact factor: 41.316

2.  Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates.

Authors:  Tobias Peikert; Sameer Rana; Eric S Edell
Journal:  Mayo Clin Proc       Date:  2005-11       Impact factor: 7.616

3.  The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies.

Authors:  L Pagano; G Pagliari; A Basso; R Marra; S Sica; L Frigieri; G Morace; F Ardito; G Leone
Journal:  Ann Med       Date:  1997-12       Impact factor: 4.709

4.  Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer.

Authors:  O Efrati; U Gonik; B Bielorai; D Modan-Moses; Y Neumann; A Szeinberg; A Vardi; A Barak; G Paret; A Toren
Journal:  Pediatr Blood Cancer       Date:  2007-03       Impact factor: 3.167

Review 5.  Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children.

Authors:  Frank-Michael C Müller; Andreas Trusen; Michael Weig
Journal:  Eur J Pediatr       Date:  2002-09-11       Impact factor: 3.183

6.  Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

Authors:  Livio Pagano; Luana Fianchi; Luca Mele; Corrado Girmenia; Massimo Offidani; Paolo Ricci; Maria E Mitra; Marco Picardi; Cecilia Caramatti; Paolo Piccaluga; Annamaria Nosari; Massimo Buelli; Bernardino Allione; Agostino Cortelezzi; Francesco Fabbiano; Giuseppe Milone; Rosangela Invernizzi; Bruno Martino; Luciano Masini; Giuseppe Todeschini; Maria A Cappucci; Domenico Russo; Laura Corvatta; Pietro Martino; Albano Del Favero
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

Review 7.  Respiratory virus infections in the immunocompromised host.

Authors:  Alexandra Soldatou; E Graham Davies
Journal:  Paediatr Respir Rev       Date:  2003-09       Impact factor: 2.726

8.  Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Thomas; T Büchner; J van de Loo
Journal:  Eur J Haematol       Date:  1995-03       Impact factor: 2.997

Review 9.  Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes.

Authors:  Andrew F Shorr; Gregory M Susla; Naomi P O'Grady
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

10.  Role of flexible bronchoscopy in the diagnosis of pulmonary infiltrates in pediatric patients with cancer.

Authors:  D C Stokes; J L Shenep; D Parham; P M Bozeman; W Marienchek; P W Mackert
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

View more
  6 in total

1.  Metagenomic Next-Generation Sequencing Successfully Detects Pulmonary Infectious Pathogens in Children With Hematologic Malignancy.

Authors:  Dao Wang; Weilin Wang; Yanjie Ding; Miaomiao Tang; Lei Zhang; Jiao Chen; Hongliang You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-28       Impact factor: 6.073

2.  Safety and Benefits of Bronchoalveolar Lavage and Lung Biopsy in the Management of Pulmonary Infiltrates in Children With Leukemia.

Authors:  Lama M Elbahlawan; Yvonne Avent; Libby Montoya; Keith Wilder; Deqing Pei; Cheng Cheng; R R Morrison; Sima Jeha
Journal:  J Pediatr Hematol Oncol       Date:  2016-11       Impact factor: 1.289

3.  Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders.

Authors:  Sruti Nadimpalli; Marc Foca; Prakash Satwani; Maria Luisa Sulis; Andrei Constantinescu; Lisa Saiman
Journal:  Pediatr Pulmonol       Date:  2017-01-03

4.  Next-generation sequencing as an advanced supplementary tool for the diagnosis of pathogens in lower respiratory tract infections: An observational trial in Xi'an, China.

Authors:  Jie Shao; Amira Hassouna; Yaqin Wang; Ruirui Zhang; Lifang Zhen; Ruidan Li; Mingli Chen; Chengjie Liu; Xiangye Wang; Mingming Zhang; Peng Wang; Shenghua Yuan; Jie Chen; Jun Lu
Journal:  Biomed Rep       Date:  2021-12-28

5.  Retrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients.

Authors:  Ali H Ahmad; Brandon D Brown; Clark R Andersen; Kris M Mahadeo; Demetrios Petropolous; José A Cortes; Shehla Razvi; Mary Katherine Gardner; Linette J Ewing; Rodrigo E Mejia
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

6.  Clinical evaluation of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid collected from children with community-acquired pneumonia.

Authors:  Wei Guo; Xiaojian Cui; Qiushi Wang; Yupeng Wei; Yanqing Guo; Tongqiang Zhang; Jianghua Zhan
Journal:  Front Med (Lausanne)       Date:  2022-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.